Atópiás dermatitisz (ekcéma): vizsgálatok itt: Egyesült Államok
77 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- No phaseTaking peopleNatural History and Genetics of Food Allergy and Related Conditions
- Where
- Bethesda
- Életkor
- 1 nap to 99 év
- People
- 1800
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT02504853 - No phaseTaking peopleMichigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project
- Where
- Ann Arbor
- Életkor
- 10 év to 55 év
- People
- 200
- Run by
- University of Michigan
See details and how to joinNCT06300697 - 1. fázisTaking peopleEvaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
- Where
- Bethesda
- Életkor
- 12 év to 120 év
- People
- 20
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07262983 - 2. fázisTaking peopleEffects of Treatments on Atopic Dermatitis
- Where
- Bethesda
- Életkor
- 2 év to 50 év
- People
- 130
- Run by
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
See details and how to joinNCT01631617 - 3. fázisTaking peopleA Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Where
- Birmingham, Charleston, Jacksonville, Macon, Miami, Norfolk, North Little Rock, Palo Alto, Portland, Sacramento, San Diego, Tampa, Tulsa, Waterford
- Életkor
- 6 hónap to 11 év
- People
- 195 worldwide
- Run by
- LEO Pharma
See details and how to joinNCT06311682 · EU 2023-503630-44-00 - Korai 1. fázisCsak meghívásosThera-Clean® Microbubbles System in Patients With Skin Diseases
- Where
- Chicago
- Életkor
- 2 év and over
- People
- 20
- Run by
- Northwestern University
See details and how to joinNCT07050810 - No phaseTaking peopleEvaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
- Where
- Caledonia, Columbus, Henderson, Las Vegas, Lee's Summit, Longview, Los Angeles, Missouri City, Morgantown, New York, Norfolk, Phoenix, Portsmouth, Rockville, South Jordan, Tampa
- Életkor
- 12 év to 89 év
- People
- 450
- Run by
- Castle Biosciences Incorporated
See details and how to joinNCT07645820 - No phaseTaking peopleBlood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- Where
- Pittsburgh
- Életkor
- 18 év and over
- People
- 200
- Run by
- University of Pittsburgh
See details and how to joinNCT00177268 - 1. fázisTaking peopleFirst-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- Where
- Birmingham, Miami, North Charleston, North Little Rock, San Antonio, Union City, West Hills, Weston
- Életkor
- 18 év to 65 év
- People
- 160 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07527923 · EU 2025-524205-32-00 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
- Where
- Arlington, Bakersfield, Birmingham, Boise, Bryant, Camp Hill, Dallas, East Syracuse, Fountain Valley, Hialeah, Huntington Beach, Hunt Valley, Indianapolis, Laguna Niguel, Los Angeles, Macon, Marietta, Memphis, Miami, Miami Lakes, Northridge, Orlando, Phoenix, Portland, Santa Ana, Southlake, Sugar Land, Tampa, Troy, Tulsa, Ypsilanti
- Életkor
- 12 év and over
- People
- 1375 worldwide
- Run by
- Pfizer
See details and how to joinNCT07783425 · EU 2026-525743-32-00 - 3. fázisTaking peopleRoflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis
- Where
- Birmingham, Bryant, Chicago, Miami Lakes
- Életkor
- 6 év and over
- People
- 415
- Run by
- Arcutis Biotherapeutics, Inc.
See details and how to joinNCT07916480 - No phaseTaking peopleStudies of Skin Microbes in Healthy People and in People With Skin Conditions
- Where
- Bethesda
- Életkor
- 2 év to 100 év
- People
- 530
- Run by
- National Human Genome Research Institute (NHGRI)
See details and how to joinNCT00605878 - 1. fázisTaking peopleFIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- Where
- Anaheim, Miami, Philadelphia, San Diego, Troy
- Életkor
- 18 év to 70 év
- People
- 119 worldwide
- Run by
- Pfizer
See details and how to joinNCT06564389 · EU 2025-524150-34-00 - 3. fázisTaking peopleA Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Where
- Birmingham, Charleston, Greenville, Indianapolis, Jacksonville, Meridian, North Little Rock, San Antonio, San Diego, St Louis
- Életkor
- 2 év to 11 év
- People
- 450 worldwide
- Run by
- Pfizer
See details and how to joinNCT06807281 · EU 2023-509124-18-00 - 2. fázisTaking peopleA Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Where
- Huntington Beach, Lorain, Los Angeles, Margate, Mayfield Heights, Miami, Northridge, Philadelphia, Phoenix, Pittsburgh, Santa Monica, Scottsdale, The Bronx
- Életkor
- 18 év to 64 év
- People
- 165 worldwide
- Run by
- Pfizer
See details and how to joinNCT07216027 · EU 2025-522965-31-00 - No phaseTaking peopleMetabolic Profiling of Immune Responses in Immune-mediated Diseases
- Where
- Bethesda
- Életkor
- 18 év to 75 év
- People
- 300
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT04864886 - 2. fázisTaking peopleA Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Where
- Boardman, Bowling Green, Charleston, Coral Gables, Dallas, Detroit, Douglasville, Fountain Valley, Frisco, Jacksonville, Los Angeles, Margate, Mason, Mill Creek, Nashville, New York, Pittsburgh, Portland, Rockville, San Antonio, Skokie, Troy, Wilmington
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Apogee Therapeutics, Inc.
See details and how to joinNCT07003425 - 1. fázisTaking peopleA Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
- Where
- New Haven
- Életkor
- 18 év to 65 év
- People
- 133 worldwide
- Run by
- Pfizer
See details and how to joinNCT07660731 · EU 2026-526260-21-00 - No phaseTaking peopleThis Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Where
- Albuquerque, Ann Arbor, Auburn Hills, Bakersfield, Bay City, Birmingham, Bolivar, Bountiful, Caledonia, Dallas, Detroit, Doral, Falls Church, Fargo, Fort Worth, Fremont, Gilbert, Huntersville, Kirksville, Las Vegas, Lincoln, Los Angeles, Macon, Marion, Mason, Mill Creek, Montgomery, Normal, North Chicago, North Miami Beach, Northridge, Oakland, Pflugerville, Phoenix, Pittsburgh, Pomona, Portsmouth, San Diego, Seattle, Spartanburg, Springville, Sugar Land, Warwick, Waterford, Wheat Ridge, Winston-Salem
- Életkor
- 12 év and over
- People
- 1000 worldwide
- Run by
- Sanofi
See details and how to joinNCT07290803 - 2. fázisTaking peopleCardamom and Topical Roseomonas in Atopic Dermatitis
- Where
- Bethesda
- Életkor
- 2 év to 100 év
- People
- 120
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT06096857 - 2. fázisTaking peopleA Study Evaluating TRIV-573 in Atopic Dermatitis
- Where
- Bay City, Boardman, Boca Raton, Camp Hill, Fountain Valley, Indianapolis, Los Angeles, Miami, Myrtle Beach, San Antonio, Spokane
- Életkor
- 18 év to 75 év
- People
- 90 worldwide
- Run by
- Triveni Bio
See details and how to joinNCT07782333 - 3. fázisCsak meghívásosA Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Where
- Bay City, Bellaire, Birmingham, Boise, Boston, Charleston, Chicago, Fairborn, Farmington, Fountain Valley, Jacksonville, Lebanon, Los Angeles, Milwaukee, North Little Rock, Owensboro, Phoenix, Sacramento, San Antonio, Tampa, Ypsilanti
- Életkor
- 6 hónap to 18 év
- People
- 338 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05735483 · EU 2022-501478-21-00 - 1. fázisTaking peoplePh 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
- Where
- College Station, Fair Lawn, Miami, Plainfield, San Antonio, South Jordan
- Életkor
- 18 év to 65 év
- People
- 125
- Run by
- Arcutis Biotherapeutics, Inc.
See details and how to joinNCT07453602 - No phaseTaking peopleDigital Mindfulness Meditation in Adolescents With Atopic Dermatitis
- Where
- New York
- Életkor
- 13 év to 17 év
- People
- 40
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT07746427 - 3. fázisTaking peopleA Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Where
- Auburn Hills, Boca Raton, Boise, Bowling Green, Clifton, Fountain Valley, Lafayette, Los Angeles, Macon, New York, Normal, North Little Rock, Oklahoma City, Omaha, Owensboro, Phoenix, St. Petersburg, Tampa, Wilmington
- Életkor
- 12 év and over
- People
- 510 worldwide
- Run by
- Nektar Therapeutics
See details and how to joinNCT07690371 · EU 2025-524925-42-00